These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 22562615

  • 1. Evaluation of drug load and polymer by using a 96-well plate vacuum dry system for amorphous solid dispersion drug delivery.
    Chiang PC, Ran Y, Chou KJ, Cui Y, Sambrone A, Chan C, Hart R.
    AAPS PharmSciTech; 2012 Jun; 13(2):713-22. PubMed ID: 22562615
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
    Murdande SB, Pikal MJ, Shanker RM, Bogner RH.
    J Pharm Sci; 2011 Oct; 100(10):4349-56. PubMed ID: 21630280
    [Abstract] [Full Text] [Related]

  • 4. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS.
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T, Taylor LS.
    Mol Pharm; 2016 Mar 07; 13(3):873-84. PubMed ID: 26791934
    [Abstract] [Full Text] [Related]

  • 7. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T, Taylor LS.
    Pharm Res; 2016 Mar 07; 33(3):739-50. PubMed ID: 26563205
    [Abstract] [Full Text] [Related]

  • 8. Comparison of two DSC-based methods to predict drug-polymer solubility.
    Rask MB, Knopp MM, Olesen NE, Holm R, Rades T.
    Int J Pharm; 2018 Apr 05; 540(1-2):98-105. PubMed ID: 29425764
    [Abstract] [Full Text] [Related]

  • 9. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE, Meier R, Daniels R, Wagner KG.
    Eur J Pharm Biopharm; 2014 Jul 05; 87(2):264-70. PubMed ID: 24768770
    [Abstract] [Full Text] [Related]

  • 10. In Vitro and In Vivo Behaviors of KinetiSol and Spray-Dried Amorphous Solid Dispersions of a Weakly Basic Drug and Ionic Polymer†.
    Jermain SV, Lowinger MB, Ellenberger DJ, Miller DA, Su Y, Williams RO.
    Mol Pharm; 2020 Aug 03; 17(8):2789-2808. PubMed ID: 32520562
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD, Ju TC, Lee PI.
    Eur J Pharm Biopharm; 2012 May 03; 81(1):149-58. PubMed ID: 22233548
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A.
    Eur J Pharm Biopharm; 2014 Sep 03; 88(1):261-74. PubMed ID: 24952357
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
    Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S.
    J Pharm Pharm Sci; 2010 Sep 03; 13(4):589-606. PubMed ID: 21486533
    [Abstract] [Full Text] [Related]

  • 17. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A, Li L, Marsac P, Marks B, Liu Z, Brown C.
    Int J Pharm; 2016 May 30; 505(1-2):107-14. PubMed ID: 27012984
    [Abstract] [Full Text] [Related]

  • 18. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE, Gao Y, Zhou D, Mo H, Zhang GGZ, Taylor LS.
    J Pharm Sci; 2011 Aug 30; 100(8):3316-3331. PubMed ID: 21607951
    [Abstract] [Full Text] [Related]

  • 19. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB, Lodagekar A, Yadav B, Shastri NR.
    Drug Deliv Transl Res; 2020 Aug 30; 10(4):903-918. PubMed ID: 32378174
    [Abstract] [Full Text] [Related]

  • 20. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S, de Armas HN, Roberts CJ, Van den Mooter G.
    J Pharm Sci; 2008 Jun 30; 97(6):2110-20. PubMed ID: 17847067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.